KAYLA MOORE: Open Payments
NPI 1386261162 · SEMINOLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 43 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $360 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $250 |
| ABBVIE INC. | 7 | $162 |
| Exact Sciences Corporation | 4 | $81 |
| Boston Scientific Corporation | 2 | $68 |
| PFIZER INC. | 4 | $64 |
| GlaxoSmithKline, LLC. | 2 | $55 |
| Lilly USA, LLC | 2 | $45 |
| Dynavax Technologies Corporation | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| SANOFI-AVENTIS U.S. LLC | 1 | $32 |
Products named: Ozempic, UBRELVY, Cologuard Collection Kit, QULIPTA, TRELEGY ELLIPTA, ELIQUIS, WATCHMAN Access System, Heplisav-B.
Industry payments across FL — which companies pay providers there.
